obesity drug news today glp-1 september 29 2025 New oral drugs could offer more options for weight loss Alarming rise in weight loss
Description
While GLP-1 medications were originally developed for type 2 diabetes, they are now widely used to manage obesity and metabolic syndrome
What mechanisms behind weight loss remain unclear
Over the years, researchers have followed this drug to see who it harms in certain organ systems and haven't seen any significant red flags in the heart or blood vessels [7]
Studies have shown that sitagliptin is a selective and potent inhibitor (greater than 80%) of the DPP-4 enzyme
Their clinic offering brings that decades-long behavioral science expertise into the GLP-1 er
July 25, 2025
